Meet our new members at Augustine Therapeutics! We are pleased to announce new appointments to our Leadership team to support the preclinical and clinical development of our peripheral-restricted and centrally acting selective HDAC6 inhibitor pipeline! Marie Trad joins us as our Chief Medical Officer with extensive experience in clinical and pharmaceutical development in the field of neurology, neuromuscular, and neuropathies, leading global clinical development from early stages throughout the lifecycle of Augustine’s assets development. Jonathan van Eyll joins as our Head of Pharmacology. His large experience spanning from in vitro and in vivo translational pharmacology to clinical disease biomarkers of neuroscience therapeutics will strengthen our expertise in accelerating the discovery and development of selective HDAC6 inhibitors for neuromuscular and neurological diseases. Finally, Cedric Szyndralewiez joins us as Head of Non-Clinical and Early Development, with a strong track record in leading and advancing multiple drug candidates through all stages of preclinical, IND approval to First-in-Patient studies. We are also expanding our discovery and development platform by joining the Leuven-based Arenberg Accelerator, accessing state-of-the-art laboratories and offices! Exciting times for Augustine Therapeutics thanks to the continuous support of our historical investors V-Bio Ventures, PMV, AdBio partners, #VIBNewVentures, VIB, and GEMMA FRISIUS - FONDS K.U.LEUVEN! To learn more about our exciting new team members, read the full Press Release here: https://lnkd.in/eabJnxNM #newappointment #biotech #team #healthcare #innovation #pharma #drugdevelopment
Happy and excited to join the adventure and drive it towards a success story
Thanks to all for the warm welcome, looking very much forward to working closely with the Augustine team of seasoned scientists and experts!
Welcome 👏
Marie Trad is a great hire
welcome to the team!
Welcome on board !
Great to see the team expand to support development of the growing and progressing pipeline. Very exciting!